DNA 시퀀싱 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The DNA Sequencing Market size is expected to reach USD 117.34 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 22.21% during 2026-2034.

The global DNA sequencing market has experienced significant growth due to advancements in genomic research and biotechnology. DNA sequencing technologies allow scientists to determine the precise order of nucleotides in genetic material, enabling deeper understanding of biological processes and diseases. These technologies are widely used in medical research, drug discovery, agriculture, and personalized medicine.

Key drivers of the DNA sequencing market include increasing research in genomics and rising demand for precision medicine. Healthcare providers and researchers use sequencing technologies to identify genetic mutations and develop targeted treatments. Declining sequencing costs and improvements in data analysis tools have also made these technologies more accessible to laboratories and research institutions.

The future prospects of the DNA sequencing market remain highly promising as genomic medicine continues to evolve. Advances in sequencing speed, accuracy, and affordability may expand its use in clinical diagnostics and healthcare. Growing investments in biotechnology and life sciences research are expected to further accelerate innovation and market growth.

MARKET SEGMENTATION

By Product & Services

• Consumables
• Instruments
• Services

By Technology

• Sanger Sequencing
• Next-Generation SequencingA (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing)
• Third Generation DNA SequencingA (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing)

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

By End-use

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc, Agilent Technology, Illumina, Inc, QIAGEN, F HoffmannLa Roche Ltd, Macrogen, Inc, PerkinElmer Genomics, PacBio, BGI, BioRad Laboratories, Inc, Myriad Genetics, PierianDx, Partek Incorporated, Eurofins Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SEQUENCING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reproductive Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinical Investigation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Agrigenomics & Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. HLA Typing/Immune System Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Metagenomics, Epidemiology & Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Consumer Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Other Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technology
  • 9.2.3 By Workflow
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technology
  • 9.3.3 By Workflow
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technology
  • 9.4.3 By Workflow
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technology
  • 9.5.3 By Workflow
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technology
  • 9.6.3 By Workflow
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA SEQUENCING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific, Inc
  • 11.2.2 Agilent Technology
  • 11.2.3 IlluminaInc
  • 11.2.4 QIAGEN
  • 11.2.5 F. Hoffmann-La Roche Ltd
  • 11.2.6 MacrogenInc
  • 11.2.7 PerkinElmer Genomics
  • 11.2.8 PacBio
  • 11.2.9 BGI
  • 11.2.10 Bio-Rad LaboratoriesInc
  • 11.2.11 Myriad Genetics
  • 11.2.12 PierianDx
  • 11.2.13 Partek Incorporated
  • 11.2.14 Eurofins Scientific